Skip to main content
Premium Trial:

Request an Annual Quote

IGTP to Use Qlucore's Omics Explorer in IBD, Crohn's Disease, Ulcerative Colitis Studies


Researchers at the Germans Trias i Pujol Foundation will use Qlucore's Omics Explorer software to support their studies of a number of diseases, including inflammatory bowel disease, Crohn's disease, and ulcerative colitis, Qlucore announced last week.

IGTP is a biomedical research institute based in Badalona, Spain, near Barcelona. Eli Pedrosa Tapias, IGTP's technical supervisor, said in a statement that the addition of Omics Explorer will make the institute's research "much more efficient … by providing our researchers with valuable data that they can interpret very quickly."

Carl-Johan Ivarsson, president of Qlucore, said IGTP's adoption of Omics Explorer is a "very powerful endorsement" for the four-year-old software company.

Omics Explorer relies on a "core engine" that visualizes data in three dimensions, helping the user to "identify hidden structures and patterns," according to its website. Qlucore claims its software can aid users in the analysis of array and RT-PCR-based gene expression; array-based DNA methylation; array-, gel-, and mass spectrometry-based protein expression; and RNA-seq.

The company's first offering was called Qlucore Gene Expression Explorer 1.0, but the name was later changed to Omics Explorer to reflect its expanded capabilities. Since its initial release in 2007, the software has been updated to achieve compatibility with a number of array platforms, including those sold by Affymetrix and Agilent Technologies.

Lund, Sweden-based Qlucore serves European customers like IGTP directly. The company earlier this month inked a distribution pact with Beijing-based SinoGenoMax to reach Asian customers (BAN 9/6/2011).

Further details of Qlucore's recent deal with IGTP were not discussed.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more